Book Cover
Home  |   Healthcare   |  CAR-T Cell Therapy Market

CAR-T Cell Therapy Market Size, Share, Growth, and Industry Analysis, By Type (CD 19,CD 20,GD2,CD22,CD30,CD33,HER1,HER2,Meso,EGFRvlll), By Application (Acute Lymphocytic,Leukemia,Chronic Lymphocytic Leukemia,Non Hodgkin Leukemia,Multiple Myeloma,Pancreatic Cancer,Neuroblasta,Breast Cancer,Acute Myeloid Leukemia,Hepatocellular Carcinoma,Colorectal Cancer), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US
Detailed TOC of Global CAR-T Cell Therapy Industry Trends Analysis Report 2025, Forecast to 2033 (Broken Down by Type, End User, Regional Analysis, and Competitive Landscape)

Table of Content_x005F_x000D_
_x005F_x000D_
1 Market Overview_x005F_x000D_
1.1 Product Definition and Market Characteristics_x005F_x000D_
1.2 Global CAR-T Cell Therapy Market Size_x005F_x000D_
1.3 Market Segmentation_x005F_x000D_
1.4 Regulatory Environment_x005F_x000D_
_x005F_x000D_
2 Industry Chain Analysis_x005F_x000D_
2.1 Industry Chain Analysis_x005F_x000D_
2.2 CAR-T Cell Therapy Raw Materials Analysis_x005F_x000D_
2.2.1 Key Raw Materials Introduction_x005F_x000D_
2.2.2 Key Suppliers of Raw Materials_x005F_x000D_
2.3 CAR-T Cell Therapy Business Mode and Production Process_x005F_x000D_
2.3.1 CAR-T Cell Therapy Business Mode Analysis_x005F_x000D_
2.3.2 Production Process Analysis_x005F_x000D_
2.4 CAR-T Cell Therapy Cost Structure Analysis_x005F_x000D_
2.4.1 Manufacturing Cost Structure of CAR-T Cell Therapy_x005F_x000D_
2.4.2 Raw Material Cost of CAR-T Cell Therapy_x005F_x000D_
2.4.3 Labor Cost of CAR-T Cell Therapy_x005F_x000D_
2.5 Market Channel Analysis_x005F_x000D_
2.6 Major Downstream Customers Analysis_x005F_x000D_
2.7 Alternative Product Analysis_x005F_x000D_
_x005F_x000D_
3 Market Dynamics_x005F_x000D_
3.1 Market Drivers_x005F_x000D_
3.2 Market Constraints and Challenges_x005F_x000D_
3.3 Emerging Market Trends_x005F_x000D_
3.4 PESTEL Analysis_x005F_x000D_
3.5 Consumer Insights Analysis_x005F_x000D_
3.6 Impact of Russia and Ukraine War_x005F_x000D_
_x005F_x000D_
4 Market Competitive Landscape_x005F_x000D_
4.1 Global CAR-T Cell Therapy Revenue and Market Share by Manufacturer (2020-2025)_x005F_x000D_
4.2 Global CAR-T Cell Therapy Sales Volume and Market Share by Manufacturer (2020-2025)_x005F_x000D_
4.3 Global CAR-T Cell Therapy Price by Manufacturer (2020-2025)_x005F_x000D_
4.4 CAR-T Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)_x005F_x000D_
4.5 Global Key Manufacturers of CAR-T Cell Therapy, Manufacturing Base Distribution and Headquarters_x005F_x000D_
4.6 Global Key Manufacturers of CAR-T Cell Therapy, Product Offered and Application_x005F_x000D_
4.7 CAR-T Cell Therapy Market Competitive Situation and Trends_x005F_x000D_
4.7.1 CAR-T Cell Therapy Market Concentration Rate_x005F_x000D_
4.7.2 Global Top 3 and Top 6 CAR-T Cell Therapy Players Market Share by Revenue_x005F_x000D_
4.8 Industry News_x005F_x000D_
4.8.1 Key Product Launch News_x005F_x000D_
4.8.2 Mergers & Acquisitions, Expansion Plans_x005F_x000D_
_x005F_x000D_
5 Global CAR-T Cell Therapy Market Historical Development by Geographic Region (2020-2025)_x005F_x000D_
5.1 Global CAR-T Cell Therapy Market Historical Sales Volume by Geographic Region (2020-2025)_x005F_x000D_
5.2 Global CAR-T Cell Therapy Market Historical Revenue by Geographic Region (2020-2025)_x005F_x000D_
5.3 North America CAR-T Cell Therapy Market Status by Country (2020-2025)_x005F_x000D_
5.3.1 North America CAR-T Cell Therapy Sales Volume by Country (2020-2025)_x005F_x000D_
5.3.2 North America CAR-T Cell Therapy Revenue by Country (2020-2025)_x005F_x000D_
5.3.3 United States CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.3.4 Canada CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.4 Europe CAR-T Cell Therapy Market Status by Country (2020-2025)_x005F_x000D_
5.4.1 Europe CAR-T Cell Therapy Sales Volume by Country (2020-2025)_x005F_x000D_
5.4.2 Europe CAR-T Cell Therapy Revenue by Country (2020-2025)_x005F_x000D_
5.4.3 Germany CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.4.4 France CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.4.5 United Kingdom CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.4.6 Spain CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.4.7 Russia CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.4.8 Poland CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.5 Asia Pacific CAR-T Cell Therapy Market Status by Country (2020-2025)_x005F_x000D_
5.5.1 Asia Pacific CAR-T Cell Therapy Sales Volume by Country (2020-2025)_x005F_x000D_
5.5.2 Asia Pacific CAR-T Cell Therapy Revenue by Country (2020-2025)_x005F_x000D_
5.5.3 China CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.5.4 Japan CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.5.5 South Korea CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.5.6 Southeast Asia CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.5.7 India CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.5.8 Australia CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.6 Latin America CAR-T Cell Therapy Market Status by Country (2020-2025)_x005F_x000D_
5.6.1 Latin America CAR-T Cell Therapy Sales Volume by Country (2020-2025)_x005F_x000D_
5.6.2 Latin America CAR-T Cell Therapy Revenue by Country (2020-2025)_x005F_x000D_
5.6.3 Mexico CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.6.4 Brazil CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.7 Middle East and Africa CAR-T Cell Therapy Market Status by Country (2020-2025)_x005F_x000D_
5.7.1 Middle East and Africa CAR-T Cell Therapy Sales Volume by Country (2020-2025)_x005F_x000D_
5.7.2 Middle East and Africa CAR-T Cell Therapy Revenue by Country (2020-2025)_x005F_x000D_
5.7.3 GCC CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
5.7.4 South Africa CAR-T Cell Therapy Sales Volume, Revenue and Growth (2020-2025)_x005F_x000D_
_x005F_x000D_
6 Global CAR-T Cell Therapy Market Historical Development by Product Type (2020-2025)_x005F_x000D_
6.1 CAR-T Cell Therapy Definition by Type_x005F_x000D_
6.2 Global CAR-T Cell Therapy Historical Sales Volume by Product Type (2020-2025)_x005F_x000D_
6.3 Global CAR-T Cell Therapy Historical Revenue by Product Type (2020-2025)_x005F_x000D_
6.4 Global CAR-T Cell Therapy Historical Price by Product Type (2020-2025)_x005F_x000D_
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2020-2025)_x005F_x000D_
6.5.1 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of CD 19 (2020-2025)
6.5.2 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of CD 20 (2020-2025)
6.5.3 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of GD2 (2020-2025)
6.5.4 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of CD22 (2020-2025)
6.5.5 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of CD30 (2020-2025)
6.5.6 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of CD33 (2020-2025)
6.5.7 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of HER1 (2020-2025)
6.5.8 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of HER2 (2020-2025)
6.5.9 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Meso (2020-2025)
6.5.10 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of EGFRvlll (2020-2025)
_x005F_x000D_
7 Global CAR-T Cell Therapy Market Historical Development by End User (2020-2025)_x005F_x000D_
7.1 Downstream Market Overview_x005F_x000D_
7.2 Global CAR-T Cell Therapy Historical Sales Volume by End User (2020-2025)_x005F_x000D_
7.3 Global CAR-T Cell Therapy Historical Revenue by End User (2020-2025)_x005F_x000D_
7.4 Global CAR-T Cell Therapy Historical Price by End User (2020-2025)_x005F_x000D_
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2020-2025)_x005F_x000D_
7.5.1 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Acute Lymphocytic (2020-2025)
7.5.2 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Leukemia (2020-2025)
7.5.3 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Chronic Lymphocytic Leukemia (2020-2025)
7.5.4 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Non Hodgkin Leukemia (2020-2025)
7.5.5 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Multiple Myeloma (2020-2025)
7.5.6 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Pancreatic Cancer (2020-2025)
7.5.7 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Neuroblasta (2020-2025)
7.5.8 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Breast Cancer (2020-2025)
7.5.9 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Acute Myeloid Leukemia (2020-2025)
7.5.10 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Hepatocellular Carcinoma (2020-2025)
7.5.11 Global CAR-T Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Colorectal Cancer (2020-2025)
_x005F_x000D_
8 Leading Companies Profiles_x005F_x000D_
8.1 Legend Biotech (Genscript Biotech Corporation)
8.1.1 Legend Biotech (Genscript Biotech Corporation) Corporation Information
8.1.2 Legend Biotech (Genscript Biotech Corporation) - CAR-T Cell Therapy Product Portfolio and Specification
8.1.3 Legend Biotech (Genscript Biotech Corporation) Performance Analysis (2020-2025)
8.1.4 Legend Biotech (Genscript Biotech Corporation) Business and Markets Served
8.1.5 Legend Biotech (Genscript Biotech Corporation) Recent Developments
8.2 Pfizer, Inc.
8.2.1 Pfizer, Inc. Corporation Information
8.2.2 Pfizer, Inc. - CAR-T Cell Therapy Product Portfolio and Specification
8.2.3 Pfizer, Inc. Performance Analysis (2020-2025)
8.2.4 Pfizer, Inc. Business and Markets Served
8.2.5 Pfizer, Inc. Recent Developments
8.3 Kite Pharma, Inc. (Gilead Sciences, Inc.)
8.3.1 Kite Pharma, Inc. (Gilead Sciences, Inc.) Corporation Information
8.3.2 Kite Pharma, Inc. (Gilead Sciences, Inc.) - CAR-T Cell Therapy Product Portfolio and Specification
8.3.3 Kite Pharma, Inc. (Gilead Sciences, Inc.) Performance Analysis (2020-2025)
8.3.4 Kite Pharma, Inc. (Gilead Sciences, Inc.) Business and Markets Served
8.3.5 Kite Pharma, Inc. (Gilead Sciences, Inc.) Recent Developments
8.4 Celgene Corporation
8.4.1 Celgene Corporation Corporation Information
8.4.2 Celgene Corporation - CAR-T Cell Therapy Product Portfolio and Specification
8.4.3 Celgene Corporation Performance Analysis (2020-2025)
8.4.4 Celgene Corporation Business and Markets Served
8.4.5 Celgene Corporation Recent Developments
8.5 Novartis International AG
8.5.1 Novartis International AG Corporation Information
8.5.2 Novartis International AG - CAR-T Cell Therapy Product Portfolio and Specification
8.5.3 Novartis International AG Performance Analysis (2020-2025)
8.5.4 Novartis International AG Business and Markets Served
8.5.5 Novartis International AG Recent Developments
8.6 CARsgen Therapeutics, Ltd.
8.6.1 CARsgen Therapeutics, Ltd. Corporation Information
8.6.2 CARsgen Therapeutics, Ltd. - CAR-T Cell Therapy Product Portfolio and Specification
8.6.3 CARsgen Therapeutics, Ltd. Performance Analysis (2020-2025)
8.6.4 CARsgen Therapeutics, Ltd. Business and Markets Served
8.6.5 CARsgen Therapeutics, Ltd. Recent Developments
8.7 Sorrento Therapeutics Inc.
8.7.1 Sorrento Therapeutics Inc. Corporation Information
8.7.2 Sorrento Therapeutics Inc. - CAR-T Cell Therapy Product Portfolio and Specification
8.7.3 Sorrento Therapeutics Inc. Performance Analysis (2020-2025)
8.7.4 Sorrento Therapeutics Inc. Business and Markets Served
8.7.5 Sorrento Therapeutics Inc. Recent Developments
8.8 Mustang Bio, Inc.
8.8.1 Mustang Bio, Inc. Corporation Information
8.8.2 Mustang Bio, Inc. - CAR-T Cell Therapy Product Portfolio and Specification
8.8.3 Mustang Bio, Inc. Performance Analysis (2020-2025)
8.8.4 Mustang Bio, Inc. Business and Markets Served
8.8.5 Mustang Bio, Inc. Recent Developments
8.9 Aurora Biopharma Inc
8.9.1 Aurora Biopharma Inc Corporation Information
8.9.2 Aurora Biopharma Inc - CAR-T Cell Therapy Product Portfolio and Specification
8.9.3 Aurora Biopharma Inc Performance Analysis (2020-2025)
8.9.4 Aurora Biopharma Inc Business and Markets Served
8.9.5 Aurora Biopharma Inc Recent Developments
_x005F_x000D_
9 Global CAR-T Cell Therapy Market Forecast by Product Type and End User (2025-2033)_x005F_x000D_
9.1 Global CAR-T Cell Therapy Market Forecast by Product Type (2025-2033)_x005F_x000D_
9.1.1 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of CD 19 (2025-2033)
9.1.2 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of CD 20 (2025-2033)
9.1.3 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of GD2 (2025-2033)
9.1.4 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of CD22 (2025-2033)
9.1.5 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of CD30 (2025-2033)
9.1.6 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of CD33 (2025-2033)
9.1.7 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of HER1 (2025-2033)
9.1.8 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of HER2 (2025-2033)
9.1.9 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Meso (2025-2033)
9.1.10 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of EGFRvlll (2025-2033)
9.2 Global CAR-T Cell Therapy Market Forecast by End User (2025-2033)_x005F_x000D_
9.2.1 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Acute Lymphocytic (2025-2033)
9.2.2 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Leukemia (2025-2033)
9.2.3 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Chronic Lymphocytic Leukemia (2025-2033)
9.2.4 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Non Hodgkin Leukemia (2025-2033)
9.2.5 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Multiple Myeloma (2025-2033)
9.2.6 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Pancreatic Cancer (2025-2033)
9.2.7 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Neuroblasta (2025-2033)
9.2.8 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Breast Cancer (2025-2033)
9.2.9 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Acute Myeloid Leukemia (2025-2033)
9.2.10 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Hepatocellular Carcinoma (2025-2033)
9.2.11 Global CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Colorectal Cancer (2025-2033)
_x005F_x000D_
10 Global CAR-T Cell Therapy Market Forecast by Geographic Region (2025-2033)_x005F_x000D_
10.1 Global CAR-T Cell Therapy Sales Volume and Revenue Forecast by Geographic Region (2025-2033)_x005F_x000D_
10.2 North America CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.2.1 United States CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.2.2 Canada CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.3 Europe CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.3.1 Germany CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.3.2 France CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.3.3 United Kingdom CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.3.4 Spain CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.3.5 Russia CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.3.6 Poland CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.4 Asia Pacific CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.4.1 China CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.4.2 Japan CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.4.3 South Korea CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.4.4 Southeast Asia CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.4.5 India CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.4.6 Australia CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.5 Latin America CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.5.1 Mexico CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.5.2 Brazil CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.6 Middle East and Africa CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.6.1 GCC CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
10.6.2 South Africa CAR-T Cell Therapy Sales Volume, Revenue Forecast and Growth (2025-2033)_x005F_x000D_
_x005F_x000D_
11 Appendix_x005F_x000D_
11.1 Methodology_x005F_x000D_
11.2 Research Data Source_x005F_x000D_
11.2.1 Secondary Data_x005F_x000D_
11.2.2 Primary Data_x005F_x000D_
11.2.3 Market Size Estimation_x005F_x000D_
11.2.4 Legal Disclaimer_x005F_x000D_
_x005F_x000D_

Captcha refresh

Trusted & Certified

Our Clients